Dr. Flora Tassone

Professor of Biochemistry, University of California, Davis

Dr. Flora Tassone

Dr. Flora Tassone is a Professor of Biochemistry at the University of California, Davis, and a molecular geneticist with over two decades of research dedicated to understanding the molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders.

Her work focuses on FMR1-associated conditions, where she has made foundational contributions to the study of CGG repeat instability, mosaicism, epigenetic regulation, and their clinical consequences. She identified FMR1 mRNA overexpression in premutation carriers, establishing RNA toxicity as a central pathogenic mechanism and contributing significantly to the characterization of fragile X–associated tremor/ataxia syndrome (FXTAS).

Her current research integrates genetic, transcriptomic, metabolomic, and proteomic approaches to develop and validate molecular biomarkers aimed at improving diagnosis, disease monitoring, and therapeutic evaluation.

Academic Highlights : 

0 +

Years of Research in Molecular Genetics

0 FMR1

Leading Research Focus

0 FXTAS

Biomarker Development & Validation

Dr. Flora Tassone Talk

Molecular Biomarkers of FXTAS

Abstract

This session will present recent advances in identifying and validating molecular biomarkers for fragile X–associated tremor/ataxia syndrome (FXTAS). Dr. Tassone will discuss integrative genetic, epigenetic, transcriptomic, and proteomic approaches that reveal molecular signatures associated with disease onset, severity, and progression. She will also highlight the translational potential of these biomarkers for improving diagnosis, patient stratification, and therapeutic evaluation.

Are You Ready?

Join a global community shaping the future of neurodevelopmental research, care, and advocacy.

Pharmacist, Scientist & Higher-Education Leader

Dr. Reem Olaby

Dr. Reem Olaby is a pharmacist, scientist, and higher-education leader actively engaged in curriculum reform, faculty development, and academic governance.

Her scholarly work focuses on the genetic, epigenetic, and proteomic underpinnings of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), Fragile X syndrome (FXS), and Fragile X–associated tremor/ataxia syndrome (FXTAS).

She is dedicated to translating molecular research into impactful education strategies, clinical training initiatives, and interdisciplinary collaboration.

Research Focus : 

Neurodevelopmental Disorders

0 +

Professional Speakers

0 +

Sponsers & Partners